Landscapes / Targets
pan-RAS
3 drugs act on pan-RAS, in 3 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Pan RAS inhibitornot checked |
— |
Phase 1/2 | Jan 2029Phase 1/2 trial completes | ||
| Next date | Jan 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Jan 2028Phase 1 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors (Phase 1), RAS Mutation | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2028Phase 1 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor (Phase I), RAS Mutation and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 3 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026